top of page
Writer's pictureSally Schwartz

Using Milk Thistle Safely for Dogs with Epilepsy: Dosage, Timing, and Potential Interactions


Milk Thistle for Dogs with Epilepsy

Milk thistle, known for its liver-protective properties, has become a popular supplement for dogs, especially those dealing with liver stress due to medication or illness. For dogs with epilepsy, whose liver function can be impacted by long-term use of anti-epileptic drugs (AEDs), milk thistle can offer valuable support. However, it’s essential to use milk thistle correctly to ensure it benefits your dog without causing unintended complications. This guide will help you understand how to safely administer milk thistle, focusing on dosage, timing, and potential interactions with AEDs.


Safe Dosage Ranges Based on Current Research


When it comes to administering milk thistle to your dog, especially one with epilepsy, dosage is crucial. While milk thistle is generally safe, the correct amount can vary depending on your dog’s size, condition, and specific needs.


Understanding Silymarin Content:


Most milk thistle supplements are standardised to contain 70-80% silymarin, the active compound responsible for its liver-protective effects. The dosage recommendations usually focus on the silymarin content rather than the total amount of milk thistle.


General Dosage Guidelines:


For dogs, a common starting dose is:


  • Tincture Form: 1/4 teaspoon per 20 lbs (9 kg) of body weight per day, split into 2 to 4 equal doses.

  • Powder Form: 2-5 mg per 1 lb (0.45 kg) of body weight, given 2 to 3 times per day.

  • Tablet Form: 1 tablet per 5 kg of body weight daily, divided into at least 2 doses.


These guidelines provide a safe range, but it’s important to read the instructions and guidelines on the specific milk thistle supplements you use and to consult with your vet.


Duration of Use:


Milk thistle is not intended for long-term, continuous use as a daily supplement. Herbalists Mary Wulff and Greg Tilford recommend using milk thistle for 3-6 weeks, followed by a 1-3 week break at a maximum usage. Typically it is recommended to use milk thistle for short sprints after acute signs of liver damage such as enzyme elevation. This approach allows the liver to benefit from milk thistle’s regenerative effects without becoming reliant on it.

 
First Aid for Canine Heatstroke: Essential Steps to Handle an Emergency
 

Best Practices for Administering Milk Thistle Alongside AEDs


Dogs with epilepsy are often on long-term AEDs like phenobarbital. These medications are essential for controlling seizures but can place significant stress on the liver over time. Integrating milk thistle into your dog’s regimen can help mitigate this stress, but it’s important to do so carefully.


Timing Is Key:


Milk thistle can be most effective when used intermittently to support the liver after periods of intense stress, such as after a course of medication that’s particularly taxing on the liver. However, it’s crucial not to administer milk thistle at the same time as AEDs. The reason is that milk thistle can potentially alter the metabolism of these drugs by affecting liver enzyme activity, which could either increase or decrease the drug’s effectiveness.


Consult with Your Veterinarian:


Before starting milk thistle, it’s always best to consult with your veterinarian, particularly if your dog is on AEDs. Your vet can help you determine the optimal timing and dosage to avoid any negative interactions and ensure that the milk thistle complements the AED regimen.


What to Look for in a Milk Thistle Brand


When selecting a milk thistle supplement for your dog, quality matters. Not all supplements are created equal, and the effectiveness of milk thistle can vary based on the formulation and purity of the product.


Standardisation and Purity:


Look for products that are standardised to contain 70-80% silymarin. This standardisation ensures that you’re providing your dog with a consistent and effective dose. Also, check for third-party testing or certification to ensure the product is free from contaminants and has the potency advertised.


Formulation:


Milk thistle is available in various forms, including capsules, tinctures, powders, and tablets. Choose the form that is easiest for you to administer and that your dog tolerates well. Phytosomal formulations, which improve the bioavailability of silymarin, are also available and might be worth considering for dogs with significant liver stress.


Avoid Unnecessary Additives:


Choose a supplement with minimal additives. Some products may contain fillers, artificial flavours, or preservatives that your dog doesn’t need. A pure, simple formulation is usually best.

 

Have Questions About Canine Epilepsy?

Join our online community of epileptic pet owners who can help you through this journey. We know how stressful it can be caring for an epileptic dog, and we are here to help.

 

Potential Side Effects and What to Watch For


While milk thistle is generally safe, it’s important to monitor your dog for any potential side effects, especially when first starting the supplement.


Common Side Effects:


Some dogs might experience mild gastrointestinal upset, such as diarrhoea or bloating, when they start taking milk thistle. These symptoms are usually temporary and can often be managed by adjusting the dosage or splitting the dose into smaller amounts throughout the day.


Allergic Reactions:


Though rare, some dogs might be allergic to milk thistle. Watch for signs of an allergic reaction, such as itching, swelling, or difficulty breathing, and discontinue use immediately if these occur.


Interactions with Medications:


As mentioned earlier, milk thistle can interact with medications metabolised by the liver. This includes AEDs and potentially other drugs your dog might be taking. Always consult with your veterinarian to ensure that milk thistle won’t interfere with your dog’s existing treatment plan.


When to Avoid Milk Thistle:


Milk thistle is generally not recommended for pregnant or lactating dogs. Additionally, if your dog has a known sensitivity to plants in the Asteraceae family (which includes daisies and ragweed), milk thistle should be used with caution or avoided altogether.

 

Has Dogileptic Helped You and Your Epi Pup 🐶?

Running this site takes resources, and we rely on donations to keep information free and accessible. If our site has helped you, please consider giving back to support our mission.

Your donation means the world to us and to dogs we help 💕

 

Conclusion: How to Use Milk Thistle Safely for Dogs with Epilepsy


Milk thistle can be a valuable tool in supporting the liver health of epileptic dogs, helping to mitigate the strain caused by long-term use of AEDs. However, safe administration is key. By following appropriate dosage guidelines, carefully timing the administration with other medications, and choosing a high-quality product, you can help ensure that your dog benefits from this natural supplement without unnecessary risks. Always consult your veterinarian before introducing any new supplement, especially when managing a complex condition like epilepsy. With the right approach, milk thistle can play a supportive role in your dog’s overall health and well-being.


References


Hackett, E. S., D. C. Twedt, and D. L. Gustafson. "Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease." *Journal of veterinary internal medicine* 27.1 (2013): 10-16.


Ludovico Abenavoli, Raffaele Capasso, Natasa Milic, Francesco Capasso. MILK THISTLE IN LIVER DISEASES: PAST, PRESENT, FUTURE. Phytotherapy Research, 2010, 24 (10), pp.1423.

10.1002/ptr.3207 . hal-00599834


Marchegiani, Andrea, et al. "Evidences on molecules most frequently included in canine and feline complementary feed to support liver function." *Veterinary Medicine International* 2020.1 (2020): 9185759.


Post-White, Janice, Elena J. Ladas, and Kara M. Kelly. "Advances in the use of milk thistle (Silybum marianum)." *Integrative cancer therapies* 6.2 (2007): 104-109.


Flora, Kenneth, et al. "Milk thistle (Silybum marianum) for the therapy of liver disease." *The American journal of gastroenterology* 93.2 (1998): 139-143.


Gogulski, Maciej, et al. "Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs." *BMC Veterinary Research* 17.1 (2021): 228.


Lakshmi, K., and K. Padmaja. "Efficacy of Silymarin and SAM in the Management of Hepatic Disorders in Dogs." *Indian Journal of Animal Research* 58.2 (2024).


Tedesco, Doriana Eurosia Angela, and Alessandro Guerrini. "Use of milk thistle in farm and companion animals: A review." *Planta Medica* 89.06 (2023): 584-607.


Watson, Penny. "Nutraceuticals and liver disease: a case-based approach." (2016): 87.


Bijak, Michal. "Silybin, a major bioactive component of milk thistle (Silybum marianum L. Gaernt.)—Chemistry, bioavailability, and metabolism." *Molecules* 22.11 (2017): 1942.


Brăteanu Teliban, Mădălina, et al. "The hepatoprotective effect of some herbal and mineral preparations in the treatment of various hepatopathies in dogs and cats." (2018).


Twedt, David. "Update on Chronic Hepatitis in Dogs.”


Nieradka, Renata. "The Effectiveness of Hepatiale Forte Advanced as hepatoprotective agent in dogs." *THE FIRST DIET ON THE MARKET TO BE A COMBINATION OF INTESTINAL AND HYPOALLERGENIC FOOD*: 20.


Martello, Elisa, et al. "Antioxidant effect of a dietary supplement containing fermentative S-acetyl-glutathione and silybin in dogs with liver disease." *Veterinary Sciences* 10.2 (2023): 131.


Abascal, Kathy, and Eric Yarnell. "The many faces of Silybum marianum (milk thistle): part 2-clinical uses, safety, and types of preparations." *Alternative & Complementary Therapies* 9.5 (2003): 251-256.


Sgorlon, Sandy, et al. "Nutrigenomic activity of plant derived compounds in health and disease: Results of a dietary intervention study in dog." *Research in veterinary science* 109 (2016): 142-148.


K. A. Skorupski, G. M. Hammond, A. M. Irish et al., “Prospective randomized clinical trial assessing the efficacy of Denamarin for prevention of CCNU-induced hepatopathy in

tumor-bearing dogs,” *Journal of Veterinary Internal Medicine*, vol. 25, no. 4, pp. 838–845, 2011.


Vogel, Günther, et al. "Protection by silibinin against Amanita phalloides intoxication in beagles." *Toxicology and applied pharmacology* 73.3 (1984): 355-362.


Floersheim, G. L., et al. "Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides." *Toxicology and applied pharmacology* 46.2 (1978): 455-462.


Desplaces, A., et al. "The effects of silymarin on experimental phalloidine poisoning." *Arzneimittel-forschung* 25.1 (1975): 89-96.


Filburn CR, Kettenacker R, Griffin DW. Bioavailability of a silybin-phosphatidylcholine complex in dogs. J Vet Pharma- col Ther 2007;30:132–138.


Valenzuela, Alfonso, et al. "Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat." *Planta medica* 55.05 (1989): 420-422.


Manna, Sunil K., et al. "Silymarin suppresses TNF-induced activation of NF-κB, c-Jun N-terminal kinase, and apoptosis." *The Journal of Immunology* 163.12 (1999): 6800-6809.


Boigk, Gabriele, et al. "Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats." *Hepatology* 26.3 (1997): 643-649.


Crocenzi, Fernando A., and Marcelo G. Roma. "Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication." *Current medicinal chemistry* 13.9 (2006): 1055-1074.


Müzes, Gy, et al. "Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)." *Orvosi hetilap* 131.16 (1990): 863-866.


Lieber, Charles S., et al. "Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons." *Journal of clinical gastroenterology* 37.4 (2003): 336-339.


Mayer, K. E., R. P. Myers, and S. S. Lee. "Silymarin treatment of viral hepatitis: a systematic review." *Journal of viral hepatitis* 12.6 (2005): 559-567.


Serviddio, Gaetano, et al. "A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis." *Journal of Pharmacology and Experimental Therapeutics* 332.3 (2010): 922-932.


Loguercio, Carmela, and Davide Festi. "Silybin and the liver: from basic research to clinical practice." *World journal of gastroenterology: WJG* 17.18 (2011): 2288.


Dunnick, June K., et al. "Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle." *Toxicologic pathology* 39.2 (2011): 398-409.

168 views0 comments

Comments


bottom of page